Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa.

Morgan CP, Allen DS, Millington-Ward S, O'Dwyer GE, Palfi A, Farrar GJ.

J Invest Dermatol. 2013 Dec;133(12):2793-6. doi: 10.1038/jid.2013.241. Epub 2013 Jun 6. No abstract available.

PMID:
23743647
[PubMed - indexed for MEDLINE]
2.

Gene therapy for recessive dystrophic epidermolysis bullosa.

Titeux M, Pendaries V, Hovnanian A.

Dermatol Clin. 2010 Apr;28(2):361-6, xii. doi: 10.1016/j.det.2010.02.003. Review.

PMID:
20447504
[PubMed - indexed for MEDLINE]
3.

siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.

Pendaries V, Gasc G, Titeux M, Tonasso L, Mejía JE, Hovnanian A.

J Invest Dermatol. 2012 Jun;132(6):1741-3. doi: 10.1038/jid.2012.11. Epub 2012 Feb 16. No abstract available.

PMID:
22336946
[PubMed - indexed for MEDLINE]
Free Article
4.

Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.

Chen M, Kasahara N, Keene DR, Chan L, Hoeffler WK, Finlay D, Barcova M, Cannon PM, Mazurek C, Woodley DT.

Nat Genet. 2002 Dec;32(4):670-5. Epub 2002 Nov 11.

PMID:
12426566
[PubMed - indexed for MEDLINE]
5.

Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.

Chamorro C, Almarza D, Duarte B, Llames SG, Murillas R, García M, Cigudosa JC, Espinosa-Hevia L, Escámez MJ, Mencía A, Meana A, García-Escudero R, Moro R, Conti CJ, Del Río M, Larcher F.

Exp Dermatol. 2013 Sep;22(9):601-3. doi: 10.1111/exd.12203.

PMID:
23947675
[PubMed - indexed for MEDLINE]
6.

Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.

Nyström A, Buttgereit J, Bader M, Shmidt T, Ozcelik C, Hausser I, Bruckner-Tuderman L, Kern JS.

PLoS One. 2013 May 23;8(5):e64243. doi: 10.1371/journal.pone.0064243. Print 2013.

PMID:
23717576
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.

Woodley DT, Krueger GG, Jorgensen CM, Fairley JA, Atha T, Huang Y, Chan L, Keene DR, Chen M.

J Invest Dermatol. 2003 Nov;121(5):1021-8.

PMID:
14708601
[PubMed - indexed for MEDLINE]
Free Article
8.

Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.

Weinel S, Lucky AW, Uitto J, Pfendner EG, Choo D.

Pediatr Dermatol. 2008 Mar-Apr;25(2):210-4. doi: 10.1111/j.1525-1470.2008.00636.x.

PMID:
18429782
[PubMed - indexed for MEDLINE]
9.

[Recessive dystrophic bullous epidermolysis: Is the etiological treatment at the streetcorner?].

Dereure O.

Ann Dermatol Venereol. 2011 Oct;138(10):710-1. doi: 10.1016/j.annder.2011.05.002. Epub 2011 Jun 8. Review. French. No abstract available.

PMID:
21978513
[PubMed - indexed for MEDLINE]
10.

Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.

Goto M, Sawamura D, Ito K, Abe M, Nishie W, Sakai K, Shibaki A, Akiyama M, Shimizu H.

J Invest Dermatol. 2006 Apr;126(4):766-72.

PMID:
16439972
[PubMed - indexed for MEDLINE]
Free Article
11.

Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.

Goto M, Sawamura D, Nishie W, Sakai K, McMillan JR, Akiyama M, Shimizu H.

J Invest Dermatol. 2006 Dec;126(12):2614-20. Epub 2006 Jun 15.

PMID:
16778792
[PubMed - indexed for MEDLINE]
Free Article
12.

A splicing mutation in the COL7A1 gene causes autosomal dominant dystrophic epidermolysis bullosa pruriginosa.

Ren X, Liu JY, Zhai LY, Yao Q, Dai X, Cai Z, Liu P, Sun K, Huang C, Wang QK, Liu M.

Br J Dermatol. 2008 Mar;158(3):618-20. No abstract available.

PMID:
18067480
[PubMed - indexed for MEDLINE]
13.

Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.

Ito K, Sawamura D, Goto M, Nakamura H, Nishie W, Sakai K, Natsuga K, Shinkuma S, Shibaki A, Uitto J, Denton CP, Nakajima O, Akiyama M, Shimizu H.

Am J Pathol. 2009 Dec;175(6):2508-17. doi: 10.2353/ajpath.2009.090347. Epub 2009 Nov 5.

PMID:
19893033
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A Japanese case of de novo dominant dystrophic epidermolysis bullosa.

Matsuba S, Suga Y, Mayuzumi N, Ikeda S, Ogawa H.

Clin Exp Dermatol. 2002 Jan;27(1):56-8.

PMID:
11952672
[PubMed - indexed for MEDLINE]
15.

Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J, Elia G, Jeffery R, Leigh IM, Navsaria H, McGrath JA.

J Invest Dermatol. 2008 Sep;128(9):2179-89. doi: 10.1038/jid.2008.78. Epub 2008 Apr 3.

PMID:
18385758
[PubMed - indexed for MEDLINE]
Free Article
16.

A novel indel COL7A1 mutation 8068del17insGA causes dominant dystrophic epidermolysis bullosa.

Sawamura D, Nizeki H, Miyagawa S, Shinkuma S, Shimizu H.

Br J Dermatol. 2006 May;154(5):995-7. No abstract available.

PMID:
16634910
[PubMed - indexed for MEDLINE]
17.

Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.

von Bartenwerffer W, Has C, Arin MJ, Tantcheva-Poór I, Kreuter A, Kremer K, Arshah T, Hoffmann M, Eming SA, Kohlhase J, Krieg T, Bruckner-Tuderman L, Hartmann K.

Eur J Dermatol. 2011 Mar-Apr;21(2):170-2. doi: 10.1684/ejd.2010.1247.

PMID:
21382783
[PubMed - indexed for MEDLINE]
18.

TALEN-based gene correction for epidermolysis bullosa.

Osborn MJ, Starker CG, McElroy AN, Webber BR, Riddle MJ, Xia L, DeFeo AP, Gabriel R, Schmidt M, von Kalle C, Carlson DF, Maeder ML, Joung JK, Wagner JE, Voytas DF, Blazar BR, Tolar J.

Mol Ther. 2013 Jun;21(6):1151-9. doi: 10.1038/mt.2013.56. Epub 2013 Apr 2.

PMID:
23546300
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.

Dang N, Murrell DF.

Exp Dermatol. 2008 Jul;17(7):553-68. doi: 10.1111/j.1600-0625.2008.00723.x. Review.

PMID:
18558993
[PubMed - indexed for MEDLINE]
20.

HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa.

Nagy N, Almaani N, Tanaka A, Lai-Cheong JE, Techanukul T, Mellerio JE, McGrath JA.

J Invest Dermatol. 2011 Aug;131(8):1771-4. doi: 10.1038/jid.2011.85. Epub 2011 Apr 7. No abstract available.

PMID:
21471992
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk